Organizational Challenges for Partial Heart Transplantation
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Partial heart transplantation (PHT) has emerged as a new treatment strategy to correct unrepairable heart valve dysfunction in pediatric patients. PHT selectively replaces the dysfunctional components of the recipient's heart and spares the native ventricles. As a result, the transplant biology of PHTs differs from heart transplants. Notably, donor hearts that are unsuitable for whole heart transplantation can be used, graft preservation can be prolonged and immunosuppression levels can be lowered. These nuances of PHT transplant biology have important implications for organizational aspects of PHT clinical application.
References
1.
Puma L, Doyle M
. Long-term psychosocial outcomes of adults transplanted in childhood: A social work perspective. Pediatr Transplant. 2020; 25(1):e13859.
DOI: 10.1111/petr.13859.
View
2.
Overbey D, Rajab T, Turek J
. Partial Heart Transplantation - How to Change the System. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2024; 27:100-105.
DOI: 10.1053/j.pcsu.2024.01.002.
View
3.
Williams R, Lu M, Sleeper L, Blume E, Esteso P, Fynn-Thompson F
. Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change. Am J Transplant. 2021; 22(3):833-842.
PMC: 9234036.
DOI: 10.1111/ajt.16921.
View
4.
Vogel A, Kwon J, Mitta A, Sherard C, Brockbank K, Rajab T
. Immunogenicity of Homologous Heart Valves: Mechanisms and Future Considerations. Cardiol Rev. 2023; 32(5):385-391.
PMC: 10363244.
DOI: 10.1097/CRD.0000000000000519.
View
5.
Lemoine C, Wall A, Testa G, Superina R
. Ethical considerations in pediatric solid organ transplantation. Semin Pediatr Surg. 2021; 30(5):151104.
DOI: 10.1016/j.sempedsurg.2021.151104.
View